SURPASSing Therapeutic Challenges of Paediatric Type 2 Diabetes with Tirzepatide

Show notes

Watch the full video on YouTube to learn more about the SURPASS-PEDS trial and the first use of a dual GIP/GLP-1 agonist in adolescents with type 2 diabetes. Explore background research on youth-onset type 2 diabetes, including rising incidence, weight-gain velocity, and metabolic progression.

Explore the latest EASD 2025 Annual Meeting presentations and view our speakers’ profiles:

  1. Dr Tamara Hannon - University of Indiana, paediatric endocrinologist and SURPASS-PEDS trial investigator
  2. Dr Martin Wabitsch - Universitätsklinikum Ulm, paediatric obesity and diabetes specialist

For more content from our previous episodes, visit our podcast archive.

New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.